Abstract: Embodiments of a paper towel holder, system and method thereof are provided. The paper towel holder includes a bracket, a sleeve, a pin and an arm. The bracket is sized and configured to be coupled to a main body of a cooking system. The sleeve defines a hollow portion to receive the pin with an axis extending axially through the sleeve, the sleeve being coupled to the bracket. The arm includes at least one opening so as to be rotatably coupled to the pin. The at least one opening in the arm extends to define a keyed shape that corresponds with a square shaped outer periphery of the sleeve such that the arm is rotatable about the pin and can be moved to different orientations about the pin.

Abstract: Embodiments of a paper towel holder, system and method thereof are provided. The paper towel holder includes a bracket, a sleeve, a pin and an arm. The bracket is sized and configured to be coupled to a main body of a cooking system. The sleeve defines a hollow portion to receive the pin with an axis extending axially through the sleeve, the sleeve being coupled to the bracket. The arm includes at least one opening so as to be rotatably coupled to the pin. The at least one opening in the arm extends to define a keyed shape that corresponds with a square shaped outer periphery of the sleeve such that the arm is rotatable about the pin and can be moved to different orientations about the pin.

Abstract: Polypeptides, nucleic acids, and compositions thereof are provided that include a targeting moiety. The polypeptides, nucleic acids, and compositions that comprise them, can be used in methods to treat subjects, to alter CAR-expressing cells in subjects who may suffer from a disease such as a cancer or a pathogen.

Abstract: The present disclosure relates to a method of modulating one or more genetically modified cells, e.g., chimeric antigen receptor (CAR)-expressing cells, ex vivo and/or in vivo.

Abstract: The disclosure describes implantable bioprosthesis and constructs having an implantable woven ribbon with at least one integrated suture.

Abstract: The disclosure describes implantable bioprosthesis and constructs having an implantable woven ribbon with at least one integrated suture.

Abstract: Methods of removing dioxane and optionally one or more CAHs such as 1,1-DCE, cis-1,2-DCE, trans-1,2-DCE, 1,2-DCA, 1,1-DCA, VC, and TCE from a liquid medium contaminated therewith include applying a feedstream of propane to the liquid medium in the presence of at least one propanotrophic bacteria strain selected from Azoarcus sp. DD4 (DD4) and Mycobacterium sp. DT1 (DT1). Propane, 1-propanol and/or 1-butanol may be employed as substrates in the bioaugmentation of the propanotrophic bacteria strain.

Abstract: Methods of removing dioxane and optionally one or more CAHs such as 1,1-DCE, cis-1,2-DCE, trans-1,2-DCE, 1,2-DCA, 1,1-DCA, VC, and TCE from a liquid medium contaminated therewith include applying a feedstream of propane to the liquid medium in the presence of at least one propanotrophic bacteria strain selected from Azoarcus sp. DD4 (DD4) and Mycobacterium sp. DT1 (DT1). Propane, 1-propanol and/or 1-butanol may be employed as substrates in the bioaugmentation of the propanotrophic bacteria strain.

Abstract: The disclosure describes methods of winding collagen fiber to make medical constructs and related collagen fiber tube and patch devices.

Abstract: Medical constructs with collagen fibers and gelatin and related collagen fibers. The collagen fibers can be derived from extruded soluble dermal collagen and can include a gelatin film attached to the at least one collagen fiber. The gelatin film can include one or more minerals and has a gelatin concentration of between about 0.1% to about 40% weight per volume.

Abstract: Medical constructs with collagen fibers and gelatin and related collagen fibers. The collagen fibers can be derived from extruded soluble dermal collagen and can include a gelatin film attached to the at least one collagen fiber. The gelatin film can include one or more minerals and has a gelatin concentration of between about 0.1% to about 40% weight per volume.

Abstract: Methods of making a biologically active three-dimensional scaffold capable of supporting growth and differentiation of a cell are described. Biologically active three-dimensional scaffold made by the methods of the invention and an engineered tissue made from the scaffolds are described. Fibers of desired porosity can be obtained from non-structural ECM by lyophilization and/or electrospinning which can be useful for numerous tissue engineering applications requiring complex scaffolds, such as wound healing, artificial skin (burns), soft tissue replacement/repair and spinal cord injury.

Abstract: The disclosure describes implantable bioprosthesis and constructs having an implantable woven ribbon with at least one integrated suture.

Abstract: The disclosure describes implantable bioprosthesis and constructs having an implantable woven ribbon with at least one integrated suture.

Abstract: Medical constructs with collagen fibers and gelatin and related collagen fibers. The collagen fibers can be derived from extruded soluble dermal collagen and can include a gelatin film attached to the at least one collagen fiber. The gelatin film can include one or more minerals and has a gelatin concentration of between about 0.1% to about 40% weight per volume.

Abstract: The present invention relates to a hybrid graft and methods of generating the hybrid graft. The hybrid graft comprises an exterior surface and a luminal surface. The luminal surface comprises a micropattern of grooves to which cells adhere and orient along. The exterior surface comprises electrospun microfibers wherein the microfibers provide mechanical properties to the graft. The hybrid graft is capable supporting endothelial cell attachment, endothelial cell alignment, cell proliferation, and maintaining their in vivo function. The graft of the invention can recapitulate the in vivo morphology and function of natural vascular endothelium.

Abstract: The disclosure describes methods of winding collagen fiber to make medical constructs and related collagen fiber tube and patch devices.

Abstract: The disclosure describes methods of winding collagen fiber to make medical constructs and related collagen fiber tube and patch devices.

Abstract: The disclosure describes methods of making collagen based biocomposite constructs and related devices. The methods include: (a) winding at least one collagen fiber a number of revolutions about a length of a support member having a long axis, the winding having at least one defined pitch and/or fiber angle relative to the long axis of the support member to form an elongate construct; and (b) applying a fluid polymeric material, such as, for example, an acrylate emulsion and/or other thermoplastic material, onto the collagen fiber during the winding step. Optionally, the fluid polymeric material can include antibiotics and/or other therapeutic agents for additional function/utility.

Abstract: The present invention relates to a hybrid graft and methods of generating the hybrid graft. The hybrid graft comprises an exterior surface and a luminal surface. The luminal surface comprises a micropattern of grooves to which cells adhere and orient along. The exterior surface comprises electrospun microfibers wherein the microfibers provide mechanical properties to the graft. The hybrid graft is capable supporting endothelial cell attachment, endothelial cell alignment, cell proliferation, and maintaining their in vivo function. The graft of the invention can recapitulate the in vivo morphology and function of natural vascular endothelium.